Sweden · Delayed Price · Currency is SEK BioGaia AB Statistics
Total Valuation
BioGaia AB has a market cap or net worth of SEK 9.66 billion. The enterprise value is 9.03 billion.
| Market Cap | 9.66B |
| Enterprise Value | 9.03B |
Important Dates
The last earnings date was Friday, July 18, 2025.
| Earnings Date | Jul 18, 2025 |
| Ex-Dividend Date | May 8, 2025 |
Share Statistics
BioGaia AB has 101.16 million shares outstanding. The number of shares has increased by 0.17% in one year.
| Current Share Class | 97.46M |
| Shares Outstanding | 101.16M |
| Shares Change (YoY) | +0.17% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.19% |
| Owned by Institutions (%) | 42.52% |
| Float | 69.67M |
Valuation Ratios
The trailing PE ratio is 33.72 and the forward PE ratio is 24.68.
| PE Ratio | 33.72 |
| Forward PE | 24.68 |
| PS Ratio | 6.71 |
| PB Ratio | 8.36 |
| P/TBV Ratio | 9.65 |
| P/FCF Ratio | 31.10 |
| P/OCF Ratio | 30.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.11, with an EV/FCF ratio of 29.09.
| EV / Earnings | 31.52 |
| EV / Sales | 6.27 |
| EV / EBITDA | 20.11 |
| EV / EBIT | 21.35 |
| EV / FCF | 29.09 |
Financial Position
The company has a current ratio of 5.74
| Current Ratio | 5.74 |
| Quick Ratio | 3.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 234.96 |
Financial Efficiency
Return on equity (ROE) is 21.00% and return on invested capital (ROIC) is 19.38%.
| Return on Equity (ROE) | 21.00% |
| Return on Assets (ROA) | 15.87% |
| Return on Invested Capital (ROIC) | 19.38% |
| Return on Capital Employed (ROCE) | 33.79% |
| Revenue Per Employee | 6.26M |
| Profits Per Employee | 1.25M |
| Employee Count | 225 |
| Asset Turnover | 0.86 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BioGaia AB has paid 77.15 million in taxes.
| Income Tax | 77.15M |
| Effective Tax Rate | 21.21% |
Stock Price Statistics
The stock price has decreased by -24.78% in the last 52 weeks. The beta is 0.63, so BioGaia AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | -24.78% |
| 50-Day Moving Average | 102.59 |
| 200-Day Moving Average | 108.87 |
| Relative Strength Index (RSI) | 35.21 |
| Average Volume (20 Days) | 151,456 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioGaia AB had revenue of SEK 1.44 billion and earned 286.63 million in profits. Earnings per share was 2.83.
| Revenue | 1.44B |
| Gross Profit | 1.04B |
| Operating Income | 423.17M |
| Pretax Income | 363.78M |
| Net Income | 286.63M |
| EBITDA | 440.33M |
| EBIT | 423.17M |
| Earnings Per Share (EPS) | 2.83 |
Balance Sheet
The company has 622.34 million in cash and n/a in debt, giving a net cash position of 622.34 million or 6.15 per share.
| Cash & Cash Equivalents | 622.34M |
| Total Debt | n/a |
| Net Cash | 622.34M |
| Net Cash Per Share | 6.15 |
| Equity (Book Value) | 1.15B |
| Book Value Per Share | 11.41 |
| Working Capital | 853.70M |
Cash Flow
In the last 12 months, operating cash flow was 315.06 million and capital expenditures -4.54 million, giving a free cash flow of 310.52 million.
| Operating Cash Flow | 315.06M |
| Capital Expenditures | -4.54M |
| Free Cash Flow | 310.52M |
| FCF Per Share | 3.07 |
Margins
Gross margin is 72.45%, with operating and profit margins of 29.39% and 19.91%.
| Gross Margin | 72.45% |
| Operating Margin | 29.39% |
| Pretax Margin | 25.27% |
| Profit Margin | 19.91% |
| EBITDA Margin | 30.58% |
| EBIT Margin | 29.39% |
| FCF Margin | 21.57% |
Dividends & Yields
This stock pays an annual dividend of 6.90, which amounts to a dividend yield of 7.01%.
| Dividend Per Share | 6.90 |
| Dividend Yield | 7.01% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 67.37% |
| Buyback Yield | -0.17% |
| Shareholder Yield | 6.84% |
| Earnings Yield | 2.97% |
| FCF Yield | 3.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.
| Last Split Date | May 18, 2022 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |